Morningstar

Seaport Therapeutics Presents Data Further Validating Glyph™ Platform’s Ability to Enhance Oral Bioavailability and Expand Therapeutic Reach

Preclinical data presented at the American Epilepsy Society (AES) Annual Meeting provide additional evidence supporting Glyph’s ability to be applied across a wide range of molecules Application of ...
Hosted on MSN

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

MELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today ...
Morningstar

Enzian Pharmaceutics demonstrates that its expandable fibrous dosage forms enhance the bioavailability of sparingly-soluble drugs

Upon ingestion, the new Enzian dosage form resides in the stomach for several hours and steadily delivers drug into the blood. This enables enhanced effectiveness of many life-saving drug therapies.
Hosted on MSN

Overcoming the solubility crisis: A solvent-free method to enhance drug bioavailability

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water. For most treatments, the oral route remains the gold ...